News

Adverse cardiac events increased during surgery while on beta-blockers


 

FROM JAMA INTERNAL MEDICINE

References

For patients who underwent noncardiac surgery, a two-drug antihypertensive treatment regimen with a beta-blocker was associated with an increased risk of perioperative major adverse cardiovascular events (MACEs) and all-cause mortality, according to research published in JAMA Internal Medicine.

Mads E. JØrgensen of Copenhagen University Hospital and his associates examined data from 671,242 surgeries performed in Denmark from 2005-2011; ultimately, 14,644 patients treated with beta-blockers and the 40,676 patients treated with other antihypertensive drugs (or 55,320 hypertensive patients using at least two antihypertensive drugs) were included in the analysis.

thegoodphoto/Thinkstockphotos.com

The incidence of 30-day MACEs and mortality was 1.32% and 1.93%, respectively, in patients treated with beta-blockers, compared with 0.84% and 1.32%, respectively, in patients treated with other drugs only (both P less than .001).

The investigators also noted that patients over age 70, men, and patients undergoing acute surgery were at greater risk for MACEs.

“This observation may suggest that perioperative management of patients with hypertension should receive specific attention in clinical practice and future guidelines, but additional randomized clinical trials on this question may be warranted,” the investigators wrote.

Read the full article in JAMA Internal Medicine (doi:10.1001/jamainternmed.2015.5346.).

mbock@frontlinemedcom.com

Recommended Reading

Hypertension, blood pressure down among U.S. children, teens
MDedge Cardiology
Proglycem found to increase pulmonary hypertension risk in infants
MDedge Cardiology
Unvetted drug indications mean safety uncertainties
MDedge Cardiology
Mobile health technology may encourage behavioral change
MDedge Cardiology
VIDEO: Napping – a novel nondrug antihypertensive therapy
MDedge Cardiology
VIDEO: Young hypertensives: Cut back on the caffeine
MDedge Cardiology
VIDEO: Spironolactone a game changer in resistant hypertension
MDedge Cardiology
Lives saved with lower systolic BP: SPRINT trial
MDedge Cardiology
When to think ‘primary aldosteronism’
MDedge Cardiology
Pregnancy complications predict mother’s premature CVD death
MDedge Cardiology